Cytoprotection behind heme oxygenase-1 in renal diseases

doi:10.5527/wjn.v1.i1.4

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4533)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

448

HTML

3657

Figures (1-1)

428

Sum=4533

Feb 6, 2012 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Nephrol. Feb 6, 2012; 1(1): 4-11
Published online Feb 6, 2012. doi: 10.5527/wjn.v1.i1.4

Full Size Figure Download Figure

Figure 1 Overview of heme oxygenase-1 in renal diseases. Heme oxygenase (HO)-1 induction prevents renal damage in diverse renal diseases, such as acute kidney injury (AKI), chronic kidney disease (CKD), diabetic nephropathy (Diabetes) and renal Transplant. Arrows followed by text indicate increase (↑) or decrease (↓). ¹Requires further study. TGF: Transforming growth factor; SMA: Smooth muscle actin; CTGF: Connective tissue growth factor; CAN: Chronic allograft nephropathy.

Citation: Correa-Costa M, Amano MT, Câmara NOS. Cytoprotection behind heme oxygenase-1 in renal diseases. World J Nephrol 2012; 1(1): 4-11
URL: https://www.wjgnet.com/2220-6124/full/v1/i1/4.htm
DOI: https://dx.doi.org/10.5527/wjn.v1.i1.4